Clinical Liver Disease
Treatment options for anti-HCV treatment-experienced patients, Peter Ferenci - Article Reading
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:08:06
- Mais informações
Informações:
Sinopse
Treatment failure with pegylated interferon (PEG-IFN)/ribavirin (RBV) dual therapy can be due to either the persistence of hepatitis C virus (HCV) RNA throughout treatment (nonresponse) or the reappearance of the virus after the end of treatment.
